Asuragen Lands $7,500,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1f33ee89-cf1a-41a1-8514-a86ed464b675&Preview=1 - Date
3/21/2013 - Company Name
Asuragen - Mailing Address
2150 Woodward St. Austin, TX 78744 - Company Description
Asuragen has its roots in Ambion, ‘The RNA Company.’ Ambion is a molecular biology reagent company with a strong focus on RNA. Asuragen is the successor entity to Ambion. - Website
http://www.asuragen.com - Transaction Type
Venture Equity - Transaction Amount
$7,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
